Diversified Trust Co. Increases Position in Intuitive Surgical, Inc. $ISRG

Diversified Trust Co. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 95.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,181 shares of the medical equipment provider’s stock after purchasing an additional 3,016 shares during the period. Diversified Trust Co.’s holdings in Intuitive Surgical were worth $3,501,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Riversedge Advisors LLC raised its stake in shares of Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after acquiring an additional 17 shares in the last quarter. Prosperity Consulting Group LLC grew its stake in Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after purchasing an additional 19 shares in the last quarter. Rossmore Private Capital grew its stake in Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after purchasing an additional 20 shares in the last quarter. Activest Wealth Management increased its holdings in Intuitive Surgical by 21.7% during the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the period. Finally, Vertex Planning Partners LLC increased its holdings in Intuitive Surgical by 2.3% during the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 21 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q4 earnings and recurring revenue remain a tailwind: ISRG posted an upside Q4 (revenue and EPS beat, revenue +18.8% y/y) and continues to benefit from high-margin recurring consumable and service sales that support profitability. (Company results and guidance underpin medium-term growth expectations.)
• Neutral Sentiment: Zacks/Yahoo coverage has ISRG as a “trending” stock, which can boost short-term flows and volatility as retail and quant strategies track momentum. Intuitive Surgical Is a Trending Stock
• Neutral Sentiment: Short-interest reports for late March appear inconsistent (multiple notices showing large increases but reporting “0 shares” / NaN). This looks like a data/reporting glitch; if meaningful shorting is actually rising it would be negative, but current published figures are unreliable.
• Negative Sentiment: Margin pressure and tariffs are a current headwind: analysts and articles note Q4 margin contraction and ongoing tariff-related cost pressure that could compress margins if costs aren’t fully offset by efficiencies. ISRG’s Margins Contract in Q4
• Negative Sentiment: Market reaction / price action: coverage noted ISRG’s larger-than-market drop today, reflecting profit-taking and sensitivity to macro/margin headlines rather than a single company-changing event. ISRG Suffers a Larger Drop Than the General Market

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 32,943 shares of company stock worth $17,279,568 in the last quarter. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $471.91 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The company has a market cap of $167.59 billion, a PE ratio of 59.81, a P/E/G ratio of 3.69 and a beta of 1.66. The business has a 50-day simple moving average of $499.14 and a two-hundred day simple moving average of $513.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.21 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ISRG. BTIG Research reiterated a “buy” rating and issued a $616.00 target price on shares of Intuitive Surgical in a report on Friday, January 23rd. Barclays set a $712.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Finally, Piper Sandler reiterated an “overweight” rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $614.95.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.